Left Menu
Development News Edition

Bollywood film 'Sui Dhaaga' to compete at Shanghai International Film Festival

ANI | Mumbai | Updated: 15-06-2019 18:04 IST | Created: 15-06-2019 17:50 IST
Bollywood film 'Sui Dhaaga' to compete at Shanghai International Film Festival
Image Credit: ANI

Varun Dhawan and Anushka Sharma starrer 'Sui Dhaaga- Made In India' has been selected to compete at the Shanghai International Film Festival The Belt and Road Film Week. Varun broke the news on his Twitter handle along with a poster of the film featuring the lead duo. He wrote, "Mauji Mamta shall be at the Shanghai international film festival as the only Hindi film chosen for the competition."

The film is based on the story of self-reliance and high spirits of the two central characters, Mamta (Anushka) and Mauji (Varun), a tailor and an embroiderer respectively, rooted in an earthy town of India. The movie narrates the story of the village couple, who dream big to start their own business together. The touches upon some heart-warming aspects of pride and self-reliance while taking forward the message of 'Made in India'.

The movie is a special salute to the inherent entrepreneurial spirit of the youth of the country and also to the local artisans who have made India proud around the world with their skills. It highlights the untapped potential of India's talented craftsmen and skilled workers at the grass-root level and the challenges and issues faced by them.

'Sui Dhaaga - Made in India' also brought together the National Award-winning producer-director duo of Maneesh Sharma and Sharat Katariya after their hit film 'Dum Laga Ke Haisha', starring Ayushmann Khurrana and Bhumi Pednekar. The film had hit the big screens on September 28 last year and received an overwhelming response from audience and critics alike.

The Shanghai International Film Festival The Belt and Road Film Week begins on Saturday.


TRENDING

OPINION / BLOG / INTERVIEW

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Poor on IHR capacity progress in 2019, WHO says Cambodia tops COVID-19 response

Despite being in proximity to Hubei, the original epicenter of COVID-19 pandemic, Cambodia has reported just 226 confirmed cases and zero deaths. After seeing the data, WHO appreciated Cambodias healthcare information system but experts dou...

Loopholes in Healthcare Information System may have failed Singapore COVID-19 model

In the initial days of the COVID-19 outbreak, Singapore was in the limelight for its effective healthcare system and pandemic response plan. However, Singapore has now joined the list of the worst-hit nations and the situation is even worse...

Australia's COVID-19 response: Digital infrastructure of help but implementation remains a challenge

Australias ongoing plans to upgrade its health information system helped by the Digital Health Strategy seem even more practical due to the pandemic. But as evident during the pandemic, administrative lapses and the complex matrix of power ...

Videos

Latest News

Wockhardt partners UK govt for COVID-19 vaccines

Drug firm Wockhardt on Monday said it has entered into an agreement with the UK government to fill-finish COVID-19 vaccines, and will undertake manufacturing at its facility in North Wales. The manufacturing will be undertaken at CP Pharmac...

Haven't confirmed my availability in any league: Irfan Pathan

Despite expressing a desire to play in the T20 Leagues around the world in the future, former Indian cricketer Irfan Pathan on Monday said he has not confirmed his availability in any league. Earlier, ESPNcricinfo had reported that Pathan i...

DCGI nod to Serum Inst. of India for phase 2 & 3 clinical trials of Oxford COVID-19 vaccine

The Drugs Controller General of India DCGI has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford Universitys COVID-19 vaccine candidate in the country, according to the Health Ministr...

Global economy could lose $108 billion in remittances: ADB

Global remittances will fall by 108.6 billion dollars if the Covid-19 economic impact persists throughout the year, the Asian Development Bank ADB said on Monday. This is equivalent to 18.3 per cent decline from what would have been expecte...

Give Feedback